受强制性开放获取政策约束的文章 - Miriam Ficial了解详情
无法在其他位置公开访问的文章：1 篇
Liver metastases from renal oncocytoma with vascular extension
G Cacciamani, L Cima, M Ficial, G Novella, S Siracusano, U Tedeschi, ...
Applied Immunohistochemistry & Molecular Morphology 27 (5), e48-e53, 2019
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute, Wellcome …
可在其他位置公开访问的文章：9 篇
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
DA Braun, Y Hou, Z Bakouny, M Ficial, M Sant’Angelo, J Forman, ...
Nature medicine 26 (6), 909-918, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
NM Tannir, S Signoretti, TK Choueiri, DF McDermott, RJ Motzer, A Flaifel, ...
Clinical Cancer Research 27 (1), 78-86, 2021
强制性开放获取政策： US National Institutes of Health
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ...
Nature communications 12 (1), 808, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Expression of T-cell exhaustion molecules and human endogenous retroviruses as predictive biomarkers for response to nivolumab in metastatic clear cell renal cell carcinoma
M Ficial, OA Jegede, M Sant'Angelo, Y Hou, A Flaifel, JC Pignon, ...
Clinical Cancer Research 27 (5), 1371-1380, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: analysis of the randomized clinical trials …
A Flaifel, W Xie, DA Braun, M Ficial, Z Bakouny, AH Nassar, RB Jennings, ...
Clinical Cancer Research 25 (20), 6080-6088, 2019
强制性开放获取政策： US National Institutes of Health
A subset of localized prostate cancer displays an immunogenic phenotype associated with losses of key tumor suppressor genes
C Calagua, M Ficial, CS Jansen, T Hirz, L Del Balzo, S Wilkinson, R Lake, ...
Clinical Cancer Research 27 (17), 4836-4847, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma
RM Saliby, T El Zarif, Z Bakouny, V Shah, W Xie, R Flippot, T Denize, ...
Cancer immunology research 11 (8), 1114-1124, 2023
强制性开放获取政策： US National Institutes of Health
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease
M Confalonieri, E Buratti, G Grassi, R Bussani, M Chilosi, R Farra, ...
PLoS One 12 (2), e0172130, 2017
强制性开放获取政策： Government of Italy
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors
Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ...
bioRxiv, 2020.05. 28.121806, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
出版信息和资助信息由计算机程序自动确定